Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation.
Ng B, Harris AC, Abdossamadi S, Aubert G, Bajwa RP, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin LM, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Savaşan S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Gilman A, Klein Geltink RI, Wolff D, Cuvelier GDE, Schultz KR. Ng B, et al. Among authors: schechter t. Blood. 2025 Oct 8:blood.2025028625. doi: 10.1182/blood.2025028625. Online ahead of print. Blood. 2025. PMID: 41060324
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.
Ng B, Harris AC, Abdossamadi S, Lauener MP, Aubert G, Bajwa R, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin L, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Savaşan S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Geltink RIK, Gilman A, Wolff D, Cuvelier GDE, Schultz KR. Ng B, et al. Among authors: schechter t. Transplant Cell Ther. 2025 Sep 29:S2666-6367(25)01458-7. doi: 10.1016/j.jtct.2025.09.034. Online ahead of print. Transplant Cell Ther. 2025. PMID: 41033605 Free article.
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.
Louloudis IE, Chen YB, Spyrou N, Alousi A, Katsivelos N, Ayuk F, Weber D, Hogan WJ, Etra AM, Qayed M, Aguayo-Hiraldo P, Akahoshi Y, Malki MMA, Bolaños-Meade J, Chanswangphuwana C, Diniz M, Eder M, Hexner E, Kitko CL, Kraus S, Merli P, Olson T, MacMillan ML, Pidala J, Reshef R, Schechter T, Wölfl M, Baez J, Eng G, Gleich S, Young R, Nakamura R, Ferrara JLM, Levine JE. Louloudis IE, et al. Among authors: schechter t. Transplant Cell Ther. 2025 Sep 25:S2666-6367(25)01456-3. doi: 10.1016/j.jtct.2025.09.038. Online ahead of print. Transplant Cell Ther. 2025. PMID: 41015085 Free PMC article.
The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD.
Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Hexner EO, Kitko CL, Kraus S, Merli P, Olson TS, Pasic I, Qayed M, Reshef R, Schechter T, Marx J, Ullrich E, Vasova I, Weber D, Wölfl M, Zeiser R, Baez J, Eng G, Gleich S, Kowalyk S, Morales G, Spyrou N, Young R, DeFilipp Z, Hogan WJ, Nakamura R, Levine JE, Ferrara JLM. Akahoshi Y, et al. Among authors: schechter t. Blood Adv. 2025 Nov 25;9(22):5763-5773. doi: 10.1182/bloodadvances.2025017116. Blood Adv. 2025. PMID: 40815797 Free PMC article.
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.
Bhatt NS, Harris AC, Gorfinkel L, Ibanez K, Tkaczyk ER, Mitchell SA, Albuquerque S, Schechter T, Pavletic S, Duncan CN, Rotz SJ, Williams K, Carpenter PA, Cuvelier GDE. Bhatt NS, et al. Among authors: schechter t. Transplant Cell Ther. 2025 Feb;31(2):69.e1-69.e18. doi: 10.1016/j.jtct.2024.12.011. Epub 2024 Dec 17. Transplant Cell Ther. 2025. PMID: 39701289
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.
Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, DeFilipp Z, Qayed M, Etra AM, Sandhu K, Kraus S, Olson T, Hexner E, Aguayo-Hiraldo P, Reshef R, Ullrich E, Schechter T, Kitko C, Chanswangphuwana C, Merli P, Akahoshi Y, Baez J, Eng G, Beheshti R, Kowalyk S, Morales G, Louloudis IE, Young R, Holler E, Nakamura R, Ferrara JLM, Levine JE. Katsivelos N, et al. Among authors: schechter t. Transplant Cell Ther. 2025 Jan;31(1):10.e1-10.e9. doi: 10.1016/j.jtct.2024.10.012. Epub 2024 Dec 11. Transplant Cell Ther. 2025. PMID: 39667999 Free PMC article.
161 results